Trump Dismisses U.S. Soldiers' Traumatic Brain Injuries From Iran Attack As 'Headaches' During Press Conference
Earlier this month, Iran launched retaliatory air strikes against Iraqi military bases where U.S. soldiers were stationed after President Donald Trump made the choice to kill top Iranian military official Qasem Soleimani.
After initial alarm, Americans breathed a sigh of relief upon learning that there were no reported casualties resulting from the attack.
Migraines affect millions of Americans. Although many medications can treat migraines once they occur, there has yet to be to be an effective FDA-approved medication that actually prevents the onset of migraines.
On May 17th, the first medication designed to prevent migraines was approved by the Food and Drug Administration. Four more preventative migraine medications are currently in the pipeline.
People who suffer from migraines may be able to prevent them months in advance, thanks to an experimental new treatment delivered intravenously four times a year. If that sounds extreme, consider this: Migraines, which can be accompanied by nausea and vomiting, extreme sensitivity to light and sound, visual disturbances, numbness in extremities, and debilitating pain, affect up to 38 million people in the U.S. and cost $36 billion in lost productivity and health care costs every year. In other words, migraines are no ordinary headache.